Key statistics
On Thursday, 4D Molecular Therapeutics Inc (FDMT:NSQ) closed at 7.99, 9.15% above its 52-week low of 7.32, set on Nov 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.41 |
---|---|
High | 8.48 |
Low | 7.83 |
Bid | 3.20 |
Offer | 8.23 |
Previous close | 8.41 |
Average volume | 1.02m |
---|---|
Shares outstanding | 51.97m |
Free float | 50.16m |
P/E (TTM) | -- |
Market cap | 415.24m USD |
EPS (TTM) | -2.76 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- 4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV
- 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
- 4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
- 4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
- 4DMT Announces Presentations at Upcoming Retina Conferences
- 4DMT to Participate in the 2024 Cantor Global Healthcare Conference
- 4DMT to Host 4D-150 Wet AMD Development Day on September 18, 2024
- 4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights
- 4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board
More ▼